142 related articles for article (PubMed ID: 16146185)
1. [Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].
Machida N; Shiotsuka S; Semba J
Seishin Shinkeigaku Zasshi; 2005; 107(7):667-73. PubMed ID: 16146185
[TBL] [Abstract][Full Text] [Related]
2. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
Reznik I; Sirota P
J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
[TBL] [Abstract][Full Text] [Related]
3. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
Reznik I; Sirota P
Clin Neuropharmacol; 2000; 23(3):157-60. PubMed ID: 10895399
[TBL] [Abstract][Full Text] [Related]
4. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
McDougle CJ; Fleischmann RL; Epperson CN; Wasylink S; Leckman JF; Price LH
J Clin Psychiatry; 1995 Nov; 56(11):526-8. PubMed ID: 7592506
[TBL] [Abstract][Full Text] [Related]
5. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.
Dwivedi S; Pavuluri M; Heidenreich J; Wright T
J Child Adolesc Psychopharmacol; 2002; 12(1):69-70. PubMed ID: 12014598
[No Abstract] [Full Text] [Related]
6. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients.
Poyurovsky M; Hermesh H; Weizman A
Clin Neuropharmacol; 1996 Aug; 19(4):305-13. PubMed ID: 8828993
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R; Kaneko S; Shinkai K; Nakamura J
Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
[TBL] [Abstract][Full Text] [Related]
8. Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up.
Bhatara V; Alshari MG; Warhol P; McMillin JM; Bhatara A
J Child Adolesc Psychopharmacol; 2004; 14(2):315-23. PubMed ID: 15319028
[TBL] [Abstract][Full Text] [Related]
9. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
10. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study.
Reznik I; Yavin I; Stryjer R; Spivak B; Gonen N; Strous R; Mester R; Weizman A; Kotler M
Pharmacopsychiatry; 2004 Mar; 37(2):52-6. PubMed ID: 15048611
[TBL] [Abstract][Full Text] [Related]
11. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
12. Risperidone-induced obsessive-compulsive symptoms in two children.
Diler RS; Yolga A; Avci A; Scahill L
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S89-92. PubMed ID: 12880504
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study.
Poyurovsky M; Isakov V; Hromnikov S; Modai I; Rauchberger B; Schneidman M; Weizman A
Int Clin Psychopharmacol; 1999 Mar; 14(2):95-100. PubMed ID: 10220124
[TBL] [Abstract][Full Text] [Related]
14. Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.
Sutor B; Hansen MR; Black JL
Downs Syndr Res Pract; 2006 Jul; 10(1):1-3. PubMed ID: 16869367
[TBL] [Abstract][Full Text] [Related]
15. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
[TBL] [Abstract][Full Text] [Related]
16. Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
Dwivedi S; Kar SK
Asian J Psychiatr; 2017 Oct; 29():160-161. PubMed ID: 29061418
[No Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B
Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of OCD].
Sumitani S; Ohmori T
Ryoikibetsu Shokogun Shirizu; 2003; (38):442-5. PubMed ID: 12877022
[No Abstract] [Full Text] [Related]
20. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Dryden-Edwards RC; Reiss AL
J Child Adolesc Psychopharmacol; 1996; 6(2):139-45. PubMed ID: 9231306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
